发明名称 |
CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases |
摘要 |
Provided are methods of suppressing complement alternative pathway in a mammalian subject in need thereof, comprising administering to said subject a therapeutically effective amount of C1q and tumor necrosis factor related protein 6 (CTRP6) or a functional analog thereof. |
申请公布号 |
US9175054(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201214116039 |
申请日期 |
2012.05.09 |
申请人 |
The University of Tokyo |
发明人 |
Iwakura Yoichiro;Murayama Masanori;Ishigame Harumichi;Kakuta Shigeru |
分类号 |
A61K38/00;C07K14/47;A61P37/02;A61K38/17;C07K14/575 |
主分类号 |
A61K38/00 |
代理机构 |
Troutman Sanders LLP |
代理人 |
Sullivan Clark G.;Troutman Sanders LLP |
主权项 |
1. A method of suppressing complement alternative pathway in a mammalian subject in need thereof, comprising administering to the subject a therapeutically effective amount of C1 q and tumor necrosis factor related protein 6 (CTRP6) or a functional analog thereof, wherein the CTRP6 or functional analog comprises the amino acid sequence selected from the group consisting of:
a) human CTRP6 (SEQ ID NO: 1); and b) the amino acid sequence having at least 95% sequence identity with C1 q domain of human CTRP6 and activity to suppress complement activation. |
地址 |
Tokyo JP |